Rehabilitation options for patients with acute PCL injuries
Official title: Kneelaxity and Self-reported Knee Function After Rehabilitation With the Use of Dynamic Kneeorthosis for Patients With Acute Isolated Posterior Cruciate Ligament Injury: A Randomized Controlled Trial
Run by Oslo University Hospital · NCT02974205 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing different rehab methods for people with recent PCL injuries to see which one helps their knee feel more stable and function better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 60 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 2 sites (Lørenskog and 1 other locations) |
| Trial ID | NCT02974205 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 16-60 who have sustained an acute isolated PCL injury within the last 21 days.
✕Probably not a fit
Patients with additional knee ligament injuries, cartilage damage, or those who are unable to participate in rehabilitation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of different rehabilitation protocols for patients with acute isolated posterior cruciate ligament (PCL) injuries. It aims to determine if one rehabilitation method leads to better knee joint stability and improved patient-reported knee function compared to others. A total of 75 patients will be randomly assigned to different treatment groups and followed up at 3 and 12 months post-injury. The outcomes will be assessed using knee laxity measurements and subjective function scores.
Why it matters
Potential benefit: If successful, this study could lead to improved rehabilitation strategies for patients with acute PCL injuries, enhancing their recovery and knee function.
How similar studies have gone: While there is limited research specifically on PCL rehabilitation, similar studies on knee ligament injuries have shown promising results with structured rehabilitation protocols.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute isolated PCL injury : 0- 3 weeks ( maximum 21 days) from the initial injury * Isolated PCL rupture (grade I, II and III) * Patient age should be between 16-60 years ( with closed epiphyseal plate ) * Understood and accepted written consent Exclusion Criteria: * Injury to the ACL or other ligaments in the knee * Extensive injury to the cartilage or meniscus , requiring repairs * Unfit to understand or to sign consent * History of alcohol or drug abuse in the past three years * Current serious illness or injury that makes rehabilitation difficult.
Where it's running
-
Akershus University Hospital
Lørenskog, Norway Recruiting -
Oslo University Hospital
Oslo, Norway Recruiting
Study contacts
- Principal investigator: Lars Engebretsen, Dr. Med — Oslo University Hospital
- Study coordinator: Ingrid Trøan, PT
- Email: ingrid.troan@ous-hf.no
- Phone: +479888593
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CM336 plus Isa-VR in newly diagnosed primary plasma cell leukemia
A new combination therapy using CM336 with isatuximab, lenalidomide, and bortezomib is being tested in adults newly diagnosed with primary plasma cell leukemia to see if it can improve treatment responses and safety.
-
Personalising Myeloma Treatment Based on Initial Response and Fitness
This trial tests whether adjusting treatment after six months of the standard DRd therapy, based on a patient’s response and fitness, can improve outcomes for older, transplant-ineligible patients with myeloma.
-
IL-15–armored CAR-T for relapsed or refractory multiple myeloma and plasma cell leukemia
This trial will test IL-15–armored CAR-T cell therapy to see if it helps adults with relapsed or refractory multiple myeloma or plasma cell leukemia, including those with persistent or returning MRD.
-
Metabolically armed BCMA CAR-T (Meta10-BCMA) for relapsed or refractory plasma cell neoplasms
This treatment tries a metabolically modified BCMA-targeted CAR-T cell therapy for adults with relapsed or refractory multiple myeloma, plasma cell leukemia, or AL amyloidosis who have had at least three prior therapies.
-
Assessing mental health disorders in Hong Kong using a new recall method
This study is testing a new way to help people in Hong Kong remember important life events to see how many have experienced major depression and thoughts of suicide.
-
AI System to Detect and Diagnose Pancreatic Cystic Lesions During Endoscopic Ultrasound
A multicenter study tests an AI system called iEUS-PCL to help detect and differentiate pancreatic cystic lesions in real time during endoscopic ultrasound.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.